Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline vs Imipenem/Cilastatin in nosocomial pneumonia
NCT00080496Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tigecycline in hospital-acquired pneumonia (HAP), sponsored by Pfizer. Started Jul 2003; status: completed.
02
Drugs
tigecycline
03
Conditions
hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on NCT00080496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080496.